Mallinckrodt Pharmaceuticals, located at 440 US-22 Suite 302 in Bridgewater, New Jersey, operates as a leading pharmaceutical company. This global business develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. The company focuses on critical areas such as autoimmune and rare diseases, covering specialties like neurology, rheumatology, and oncology.
The Specialty Brands segment emphasizes innovative therapies for complex conditions. This includes immunotherapy and neonatal respiratory critical care, as well as analgesics and cultured skin substitutes. The Specialty Generics segment provides a range of specialty generic drugs and active pharmaceutical ingredients. Mallinckrodt’s commitment to addressing unmet medical needs reflects its dedication to improving patient outcomes.
With a robust portfolio, Mallinckrodt Pharmaceuticals stands out in the competitive pharmaceutical landscape. The company’s focus on specialty areas positions it to tackle some of the most pressing health challenges today. Its ongoing research and development efforts contribute to advancements in treatment options, benefiting patients and healthcare providers alike. Quality and innovation drive the company’s mission, ensuring a reliable supply of essential medications.
Mallinckrodt Pharmaceuticals offers a comprehensive array of specialty products and therapies aimed at improving health outcomes. The company’s expertise in multiple therapeutic areas demonstrates its strength in the pharmaceutical industry. Reach out to Mallinckrodt Pharmaceuticals in Bridgewater, New Jersey, for specialized pharmaceutical services and innovative solutions.
